| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
257 |
249 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
71 |
71 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
224 |
224 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
216 |
216 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
131 |
131 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
96 |
96 |
$3K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13 |
13 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$1K |
| 87481 |
|
12 |
12 |
$870.12 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
26 |
$682.98 |
| 99401 |
|
13 |
13 |
$426.92 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$305.76 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$282.24 |
| 85027 |
|
34 |
33 |
$276.38 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26 |
24 |
$246.71 |
| 81025 |
|
31 |
31 |
$231.52 |
| 86780 |
|
13 |
13 |
$197.95 |
| 87220 |
|
33 |
31 |
$165.66 |
| 87340 |
|
13 |
13 |
$154.58 |
| 83986 |
|
35 |
33 |
$146.95 |
| 82120 |
|
33 |
31 |
$146.35 |
| 87210 |
|
18 |
16 |
$90.42 |